Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

hyaluronidase

hyaluronidase
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Amphadase SOLUTION, INJECTABLE 150 units/mL      
Hylenex SOLUTION, INJECTABLE 150 units/mL preservative free      
Vitrase SOLUTION, INJECTABLE 200 units/mL      
VIEW MORE Enzymes
CLASS
440000
Comments:

Amphadase is the formulary product. Amphadase should be substituted for Vitrase except in the unusual case of an allergy to bovine products.

HYLENEX is classified as restricted to the pediatric setting for patients with mild to moderate dehydration and difficult venous access or Adult Vesicant Extravastation Management Order Set.

HYLENEX Reviewed: November 17, 2009

Reviewed: October 26, 2005 (Amphadase and Vitrase)

Last updated: Feb. 25, 2019






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved